Lanoc (Metoprolol Tartrate)

Metoprolol tartrate selectively blocks β1‑adrenergic receptors in the heart, decreasing the effects of adrenaline and noradrenaline. This leads to reduced heart rate, lower myocardial contractility, and diminished cardiac output, which together lower blood pressure and reduce the heart's oxygen demand.

The appropriate dose of Lanoc is determined by the prescribing clinician based on the patient’s medical condition, response to therapy, and other individual factors. Dosage may be adjusted over time, and patients should follow the prescriber’s instructions without self‑adjusting the amount.

Safety of metoprolol tartrate during pregnancy or lactation has not been definitively established. Healthcare providers weigh potential benefits against possible risks before prescribing. Patients who are pregnant, planning to become pregnant, or breastfeeding should discuss their situation with a qualified medical professional.

To request Lanoc, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifying trade or institutional credentials before providing pricing, availability, shipping details, and necessary import documentation.

Lanoc (metoprolol tartrate) is a cardio‑selective β1‑blocker, offering targeted heart effects with fewer respiratory side effects compared with non‑selective agents like propranolol. Its pharmacokinetic profile allows once‑ or twice‑daily dosing, making it a common choice for hypertension, angina, and heart failure management.

Lanoc should be stored at temperatures below 25 °C, in its original packaging to protect from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments to maintain its stability.

Lanoc is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with a glass of water. Patients should not crush or chew the tablets unless specifically instructed by a healthcare professional.

Serious adverse events can include severe bradycardia, heart block, marked hypotension, bronchospasm in susceptible individuals, and depression or mood changes. Patients should seek immediate medical attention if they experience fainting, extreme fatigue, difficulty breathing, or any sudden worsening of symptoms.

Lanoc is contraindicated in patients with known hypersensitivity to metoprolol or any component of the formulation, those with severe sinus bradycardia, second‑ or third‑degree atrioventricular block without a pacemaker, and individuals with uncompensated heart failure or cardiogenic shock.